The global eyelid surgery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. Cosmetic surgery center acquisitions are driving this growth, enhancing market presence, resources, and brand recognition. Key players such as Athenix and H/K/B Cosmetic Surgery are innovating, partnering, and expanding to meet rising global demand. In this dynamic landscape, strategic acquisitions within the cosmetic surgery sector are emerging as a driving force behind the expansion of the eyelid surgery market. These acquisitions offer a multitude of benefits, including increased market penetration, optimized resource allocation, and heightened brand visibility. For instance, in June 2023, H/K/B Cosmetic Surgery has successfully acquired Lowcountry Plastic Surgery Center, a move that culminates in the center's rebranding as H/K/B Mount Pleasant. This strategic acquisition aligns seamlessly with H/K/B Cosmetic Surgery's ongoing expansion initiatives, which have already encompassed practices across South Carolina and Tennessee. The acquisition serves as a deliberate and well-calculated step towards broadening both their reach and service portfolio within the Mount Pleasant area.
Browse the full report description of “Eyelid Surgery Market Size, Share & Trends Analysis Report by Procedure Type (Upper Eyelid Surgery, Lower Eyelid Surgery) and by End User (Clinics & Surgery Centers, Hospitals) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/eyelid-surgery-market
In February, 2023, Athenix, a prominent US-based medical practice specializing in plastic surgery procedures, has recently acquired Marina Plastic Surgery and MedSpa located in Marina Del Rey, California. The core objective behind this acquisition is to amplify Athenix's footprint within the plastic surgery industry. Additionally, the move aims to fortify Athenix's array of service offerings, solidifying its position as a leading player in the field.
Hence, the eyelid surgery market's accelerated growth is powered by strategic acquisitions within the cosmetic surgery domain. Industry leaders' proactive approach to innovation, partnerships, and expansion is driving substantial progress in meeting the global demand for eyelid surgery procedures.
Market Coverage
• The market number available for – 2023-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Procedure Type
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Includes Galderma SA, Cutera Inc., Stanford Health Care, Anika Therapeutics Inc, and AbbVie Inc., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Eyelid Surgery Market Report Segment
By Procedure Type
By End User
Global Eyelid Surgery Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/eyelid-surgery-market